Core A: Administrative Core
Core A: Administrative Core
批准号:
10264188
负责人:
ERIC MICHAEL REIMAN
金额:
$28.71万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-05 至 2026-06-30
关键词:
AccountabilityAdherenceAdultAdvisory CommitteesAffectAgingAllelesAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaArizonaBindingBiologicalBlood specimenBrainClinicalClinical ResearchCollaborationsCommunicationCommunitiesDataDevelopmentDiagnosisDiseaseDoseEarly DiagnosisEnsureEthicsEvaluationFamilyFeedbackFundingGluesGoalsGrantGuidelinesHispanicsInvestmentsLatinoLeadershipMinorityMinority GroupsModelingMonitorNative AmericansParticipantPersonsPhilanthropic FundPilot ProjectsPrevention therapyProgram ReviewsRecommendationResearchResearch PersonnelResource SharingResourcesRoleSamplingSecureTimeUnderrepresented MinorityUnderrepresented PopulationsUnited States National Institutes of HealthValidationVisionWorkaging brainblood resourceblood-based biomarkercareerclinical careclinical research sitecohortdata sharingdrug developmentfight againstneuropathologynext generationoutreachparticipant enrollmentpreclinical studyprogramsresearch and developmentresearch studysuccesstherapy development
中文摘要
项目摘要/摘要-行政核心(核心a)
英文摘要
PROJECT SUMMARY/ABSTRACT - ADMINISTRATIVE CORE (CORE A)
The Administrative Core will provide scientific and administrative leadership, vision, direction, coordination,
integration, management, oversight, resource-sharing and collaborative mandates, support, and accountability
for the Arizona Alzheimer's Disease Research Center (ADRC). It will also provide the scientific leadership and
hub for more than 150 researchers from twelve participating organizations in the Arizona Alzheimer's
Consortium (AAC), making it possible to dramatically augment and optimize the utilization of our shared
resources, support a wide range of researcher studies, develop new research and clinical programs and the
next generation of AD and related dementia (ADRD) researchers, and further develop our statewide model of
collaboration in AD research. It will permit our ADRC Cores, organizationally supported Affiliated Brain and
Body Donation Program (BBDP), Affiliated APOE Program, and pending NIA grant-supported APOE4/APOE2
Allelic Dose Cohort to provide a shared resource of annual NACC- and NCRAD-shared data and samples from
about 1,650 research participants per year, including about 100 participants per year who donate their brains
and have comprehensive neuropathological assessments after they die, and support our overarching theme:
“blood-based biomarkers (BBBs) in the diagnosis, preclinical study and prevention of AD.” It will capitalize on
longstanding relationships with our Cores, REC, Affiliated Programs, researchers, clinicians, and
organizational and state leaders, a strong record of close working relationships and success, a shared
commitment to the prevention of AD, and the proposed ADRC's very existence to help secure and leverage
major state, organization and philanthropic investments, maximize the ADRC's impact, fulfill its ambitious and
aggressively collaborative goals, and continue to make the fight against ADRD a top priority in Arizona. It will
work closely with NIA, NACC, NCRAD, other ADRCs and research programs, and a wide range of other
organizations and stakeholder groups, partner with two Resource Centers for Minority Aging Research
(RCMARs), our Cores and REC to help develop ADRD-related Native American and Hispanic/Latino
researchers, research participant enrollment, and studies. It will administer the ADRC's program for the
solicitation, competitive evaluation, and support of four NIA-sponsored 24-month Developmental Projects and
ten state-supported 12-month Pilot Projects during the funding period. It will capitalize on ADRC, Gates
Ventures and organizational funds to help establish an invaluable resource of NACC and NCRAD-shared data
and biological samples for the validation of emerging BBBs in brain donation program participants and
underrepresented minority groups and support their potentially transformational roles in AD research drug
development, research and clinical care, increase the opportunity for our researchers, colleagues and
collaborators to find and support the availability and affordability of an AD prevention therapy in 2025, and help
fulfill the goals of the National Alzheimer's Project Act (NAPA).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Arizona Alzheimer's Disease Research Center
-
批准号:10264187
-
项目类别:
-
资助金额:$321.7万
-
财政年份:2021
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Arizona Alzheimer's Disease Research Center
-
批准号:10656488
-
项目类别:
-
资助金额:$312.88万
-
财政年份:2021
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Alzheimer's Prevention Initiative APOE4 Trial
-
批准号:8605297
-
项目类别:
-
资助金额:$3326.02万
-
财政年份:2013
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Cyclotron, PET and MRI Facility Improvement: A Scientific Resource for Arizona
-
批准号:7898499
-
项目类别:
-
资助金额:$653.02万
-
财政年份:2010
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
The GE PETtrace Cyclotron: A Scientific Resource for the State of Arizona
-
批准号:7840169
-
项目类别:
-
资助金额:$265.23万
-
财政年份:2010
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Arizona Alzheimer's Disease Core Center
-
批准号:8118361
-
项目类别:
-
资助金额:$5.65万
-
财政年份:2010
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
PET, APOE & the Preclinical Course of Alzheimer's Disease
-
批准号:8050044
-
项目类别:
-
资助金额:$128.66万
-
财政年份:2008
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
PET, APOE & the Preclinical Course of Alzheimer's Disease
-
批准号:7596924
-
项目类别:
-
资助金额:$133.55万
-
财政年份:2008
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
PET, APOE & the Preclinical Course of Alzheimer's Disease
-
批准号:7383433
-
项目类别:
-
资助金额:$130.31万
-
财政年份:2008
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
PET, APOE & the Preclinical Course of Alzheimer's Disease
-
批准号:8234924
-
项目类别:
-
资助金额:$124.6万
-
财政年份:2008
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
PET, APOE & the Preclinical Course of Alzheimer's Disease
-
批准号:7796651
-
项目类别:
-
资助金额:$129.66万
-
财政年份:2008
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Arizona Alzheimer's Disease Core Center
-
批准号:6353922
-
项目类别:
-
资助金额:$93.36万
-
财政年份:2001
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Neuropathology Core
-
批准号:8379351
-
项目类别:
-
资助金额:$29.55万
-
财政年份:2001
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Clinical Core
-
批准号:8805816
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2001
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Neuropathology Core
-
批准号:8691621
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2001
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Education and Information Transfer Core
-
批准号:8691622
-
项目类别:
-
资助金额:$5.65万
-
财政年份:2001
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Clinical Core
-
批准号:8796285
-
项目类别:
-
资助金额:$48.36万
-
财政年份:2001
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Arizona Alzheimer's Disease Core Center
-
批准号:7666360
-
项目类别:
-
资助金额:$8.03万
-
财政年份:2001
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Education and Information Transfer Core
-
批准号:8379352
-
项目类别:
-
资助金额:$13.2万
-
财政年份:2001
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
Arizona Alzheimer's Disease Core Center
-
批准号:7287442
-
项目类别:
-
资助金额:$136.9万
-
财政年份:2001
-
负责人:ERIC MICHAEL REIMAN
-
依托单位:
海外基金